发布求助
文献互助 智能选刊 最新文献

Journal of the National Comprehensive Cancer Network最新文献

筛选
英文 中文
HSR25-194: Trends in Depression and Its Unequal Burden in Cancer Survivors With Socioeconomic Disparities. HSR25-194：具有社会经济差异的癌症幸存者的抑郁趋势及其不平等负担。
IF 14.8 2区 医学
Journal of the National Comprehensive Cancer Network Pub Date : 2025-03-28 DOI: 10.6004/jnccn.2024.7172
Amara Sofia, Ahmad Alhomaid, Nency K Ganatra, Aditya Sanjeevi, Rupak Desai, Akhil Jain, Rishika Trivedi
{"title":"HSR25-194: Trends in Depression and Its Unequal Burden in Cancer Survivors With Socioeconomic Disparities.","authors":"Amara Sofia, Ahmad Alhomaid, Nency K Ganatra, Aditya Sanjeevi, Rupak Desai, Akhil Jain, Rishika Trivedi","doi":"10.6004/jnccn.2024.7172","DOIUrl":"https://doi.org/10.6004/jnccn.2024.7172","url":null,"abstract":"","PeriodicalId":17483,"journal":{"name":"Journal of the National Comprehensive Cancer Network","volume":"23 3.5","pages":""},"PeriodicalIF":14.8,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143743722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EPR25-121: Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Cancer Patients: Testing and Referral Guidelines. EPR25-121：癌症患者的不确定潜力（CHIP）克隆造血：测试和转诊指南。
IF 14.8 2区 医学
Journal of the National Comprehensive Cancer Network Pub Date : 2025-03-28 DOI: 10.6004/jnccn.2024.7239
Teodora Kuzmanovic, Maedeh Zoakei Nikoo, Sindhusha Veereballi, Ahmad Safdar, Sakthi S Prakash, Emmett Samsa, David Bosler, Halle C F Moore, Jame Abraham, Jessica Geiger, Aaron T Gerds, Anjali S Advani, Sudipto Mukherjee, John C Molina, Sophia Balderman, Moaath Mustafa Ali, Jaroslaw P Maciejewski, Akriti Jain, Hetty Carraway, Bhumika Patel, Rohit Moudgil, Abhay Singh
{"title":"EPR25-121: Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Cancer Patients: Testing and Referral Guidelines.","authors":"Teodora Kuzmanovic, Maedeh Zoakei Nikoo, Sindhusha Veereballi, Ahmad Safdar, Sakthi S Prakash, Emmett Samsa, David Bosler, Halle C F Moore, Jame Abraham, Jessica Geiger, Aaron T Gerds, Anjali S Advani, Sudipto Mukherjee, John C Molina, Sophia Balderman, Moaath Mustafa Ali, Jaroslaw P Maciejewski, Akriti Jain, Hetty Carraway, Bhumika Patel, Rohit Moudgil, Abhay Singh","doi":"10.6004/jnccn.2024.7239","DOIUrl":"https://doi.org/10.6004/jnccn.2024.7239","url":null,"abstract":"","PeriodicalId":17483,"journal":{"name":"Journal of the National Comprehensive Cancer Network","volume":"23 3.5","pages":""},"PeriodicalIF":14.8,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143743472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HSR25-200: Evaluation of a Patient Navigation System on Cancer Treatment Milestones in a Rural Cancer Center. HSR25-200：对农村癌症中心癌症治疗里程碑患者导航系统的评估。
IF 14.8 2区 医学
Journal of the National Comprehensive Cancer Network Pub Date : 2025-03-28 DOI: 10.6004/jnccn.2024.7283
Stephanie Lourdes Echeverria, John Ashurst, Edgardo Rivera, Anthony Santarelli, Diana Lalitsasivimol
{"title":"HSR25-200: Evaluation of a Patient Navigation System on Cancer Treatment Milestones in a Rural Cancer Center.","authors":"Stephanie Lourdes Echeverria, John Ashurst, Edgardo Rivera, Anthony Santarelli, Diana Lalitsasivimol","doi":"10.6004/jnccn.2024.7283","DOIUrl":"10.6004/jnccn.2024.7283","url":null,"abstract":"","PeriodicalId":17483,"journal":{"name":"Journal of the National Comprehensive Cancer Network","volume":"23 3.5","pages":""},"PeriodicalIF":14.8,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143743727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BPI25-017: A Novel Integrated Classification Schema for Molecular Findings by Potential Clinical Actionability: A Tool for Assessment of Real-World Cancer Care in the Targeted Therapy Era. BPI25-017：一种基于潜在临床可操作性的分子发现的新型集成分类模式：在靶向治疗时代评估真实世界癌症治疗的工具。
IF 14.8 2区 医学
Journal of the National Comprehensive Cancer Network Pub Date : 2025-03-28 DOI: 10.6004/jnccn.2024.7205
Xiao Wang, Jessica B Long, John Rothen, Pamela R Soulos, Timothy J Robinson, Carolyn J Presley, Sarah B Goldberg, Ronac Mamtani, Shi-Yi Wang, Natalia Kunst, Shuangge Ma, Sida Huang, Cary P Gross, Michaela A Dinan
{"title":"BPI25-017: A Novel Integrated Classification Schema for Molecular Findings by Potential Clinical Actionability: A Tool for Assessment of Real-World Cancer Care in the Targeted Therapy Era.","authors":"Xiao Wang, Jessica B Long, John Rothen, Pamela R Soulos, Timothy J Robinson, Carolyn J Presley, Sarah B Goldberg, Ronac Mamtani, Shi-Yi Wang, Natalia Kunst, Shuangge Ma, Sida Huang, Cary P Gross, Michaela A Dinan","doi":"10.6004/jnccn.2024.7205","DOIUrl":"10.6004/jnccn.2024.7205","url":null,"abstract":"","PeriodicalId":17483,"journal":{"name":"Journal of the National Comprehensive Cancer Network","volume":"23 3.5","pages":""},"PeriodicalIF":14.8,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143743267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HSR25-172: Meta-Analysis of Phase 3 Randomized Controlled Trials to Evaluate the Incidence of Infectious Adverse Events in Patients With Relapsed/Refractory Multiple Myeloma Treated With Belantamab Mafodotin. HSR25-172: 3期随机对照试验的荟萃分析，评估贝兰他单抗治疗的复发/难治性多发性骨髓瘤患者感染不良事件的发生率。
IF 14.8 2区 医学
Journal of the National Comprehensive Cancer Network Pub Date : 2025-03-28 DOI: 10.6004/jnccn.2024.7314
Riccesha Hattin, Hazem Aboaid, Abbas Hussain, Savannah Schauer, Tal Schlesinger, Rory Twells, Karl Aharonian, Ryan Parto, Rodd Rahmani, Chalette Lambert-Swainston, Daniel Thomas Jones, Ramaditya Srinivasmurthy, Kyaw Zin Thein, Thura Win Htut
{"title":"HSR25-172: Meta-Analysis of Phase 3 Randomized Controlled Trials to Evaluate the Incidence of Infectious Adverse Events in Patients With Relapsed/Refractory Multiple Myeloma Treated With Belantamab Mafodotin.","authors":"Riccesha Hattin, Hazem Aboaid, Abbas Hussain, Savannah Schauer, Tal Schlesinger, Rory Twells, Karl Aharonian, Ryan Parto, Rodd Rahmani, Chalette Lambert-Swainston, Daniel Thomas Jones, Ramaditya Srinivasmurthy, Kyaw Zin Thein, Thura Win Htut","doi":"10.6004/jnccn.2024.7314","DOIUrl":"10.6004/jnccn.2024.7314","url":null,"abstract":"","PeriodicalId":17483,"journal":{"name":"Journal of the National Comprehensive Cancer Network","volume":"23 3.5","pages":""},"PeriodicalIF":14.8,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143743634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
QIM25-232: Extracellular Vesicles Evade the Antiangiogenic Effect of Bevacizumab in Ovarian Cancer. QIM25-232：细胞外囊泡逃避贝伐单抗在卵巢癌中的抗血管生成作用。
IF 14.8 2区 医学
Journal of the National Comprehensive Cancer Network Pub Date : 2025-03-28 DOI: 10.6004/jnccn.2024.7302
Zhuoye Chen, Conghui Wang, Mingxia Xu, Tingjia Zhu, Yuehan Wang, Xiaodong Cheng, Xinyu Wang
{"title":"QIM25-232: Extracellular Vesicles Evade the Antiangiogenic Effect of Bevacizumab in Ovarian Cancer.","authors":"Zhuoye Chen, Conghui Wang, Mingxia Xu, Tingjia Zhu, Yuehan Wang, Xiaodong Cheng, Xinyu Wang","doi":"10.6004/jnccn.2024.7302","DOIUrl":"10.6004/jnccn.2024.7302","url":null,"abstract":"","PeriodicalId":17483,"journal":{"name":"Journal of the National Comprehensive Cancer Network","volume":"23 3.5","pages":""},"PeriodicalIF":14.8,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143742985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
YIA25-001: Molecular Residual Disease (MRD) Guided Adjuvant Therapy In Renal Cell Carcinoma (RCC) - The MRD GATE RCC Study. 分子残留病（MRD）引导肾细胞癌（RCC）的辅助治疗- MRD GATE RCC研究。
IF 16.4 2区 医学
Journal of the National Comprehensive Cancer Network Pub Date : 2025-03-28 DOI: 10.6004/jnccn.2024.7289
Arnab Basu, Fady Sidhom, Caleb Hwang, James Ferguson, Charles Peyton, Sejong Bae, Deepak Kilari, Arpita Desai, Soroush Rais-Bahrami
{"title":"YIA25-001: Molecular Residual Disease (MRD) Guided Adjuvant Therapy In Renal Cell Carcinoma (RCC) - The MRD GATE RCC Study.","authors":"Arnab Basu, Fady Sidhom, Caleb Hwang, James Ferguson, Charles Peyton, Sejong Bae, Deepak Kilari, Arpita Desai, Soroush Rais-Bahrami","doi":"10.6004/jnccn.2024.7289","DOIUrl":"10.6004/jnccn.2024.7289","url":null,"abstract":"","PeriodicalId":17483,"journal":{"name":"Journal of the National Comprehensive Cancer Network","volume":"23 3.5","pages":""},"PeriodicalIF":16.4,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143743348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HSR25-186: A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of General Systemic Adverse Events in Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors. HSR25-186：随机对照试验的系统回顾和荟萃分析，以评估局部晚期头颈部鳞状细胞癌接受免疫检查点抑制剂治疗的一般全身不良事件的风险。
IF 14.8 2区 医学
Journal of the National Comprehensive Cancer Network Pub Date : 2025-03-28 DOI: 10.6004/jnccn.2024.7329
Taimur Khalid, Hazem Aboaid, Daniel Thomas Jones, Jason Ta, Ramaditya Srinivasmurthy, Kenny Do, Kevin Nguyen, Karina Fama, Rishi Kumar Nanda, Sarah Aamer, Jo-Lawrence Bigcas, Kyaw Zin Thein
{"title":"HSR25-186: A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of General Systemic Adverse Events in Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors.","authors":"Taimur Khalid, Hazem Aboaid, Daniel Thomas Jones, Jason Ta, Ramaditya Srinivasmurthy, Kenny Do, Kevin Nguyen, Karina Fama, Rishi Kumar Nanda, Sarah Aamer, Jo-Lawrence Bigcas, Kyaw Zin Thein","doi":"10.6004/jnccn.2024.7329","DOIUrl":"10.6004/jnccn.2024.7329","url":null,"abstract":"","PeriodicalId":17483,"journal":{"name":"Journal of the National Comprehensive Cancer Network","volume":"23 3.5","pages":""},"PeriodicalIF":14.8,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143753362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CLO25-074: Outcomes to Immune Checkpoint Inhibitors (ICIs) According to Programmed Death-Ligand 1 (PD-L1) Levels in KRAS-, KEAP1-, STK11-Mutant Lung Squamous Cell Carcinoma (LSCC). CLO25-074：免疫检查点抑制剂（ICIs）在KRAS-， KEAP1-， stk11 -突变型肺鳞状细胞癌（LSCC）中根据程序性死亡配体1 （PD-L1）水平的结果
IF 14.8 2区 医学
Journal of the National Comprehensive Cancer Network Pub Date : 2025-03-28 DOI: 10.6004/jnccn.2024.7142
Justin W Shi, Ahmad Karkash, Weston He, Mya T Tran, Yan Han, Misty Dawn Shields, Julian A Marin-Acevedo
{"title":"CLO25-074: Outcomes to Immune Checkpoint Inhibitors (ICIs) According to Programmed Death-Ligand 1 (PD-L1) Levels in KRAS-, KEAP1-, STK11-Mutant Lung Squamous Cell Carcinoma (LSCC).","authors":"Justin W Shi, Ahmad Karkash, Weston He, Mya T Tran, Yan Han, Misty Dawn Shields, Julian A Marin-Acevedo","doi":"10.6004/jnccn.2024.7142","DOIUrl":"10.6004/jnccn.2024.7142","url":null,"abstract":"","PeriodicalId":17483,"journal":{"name":"Journal of the National Comprehensive Cancer Network","volume":"23 3.5","pages":""},"PeriodicalIF":14.8,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143753378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BPI25-006: Triage for Screening Programs: Colour Coding High-Risk Patients. BPI25-006：筛选项目的分类：高危患者的颜色编码。
IF 14.8 2区 医学
Journal of the National Comprehensive Cancer Network Pub Date : 2025-03-28 DOI: 10.6004/jnccn.2024.7179
Carol-Ann Benn, Dominic van Loggereneberg, Charl van Loggereneberg, Bernado Rapoport, Tanya Volschenk
{"title":"BPI25-006: Triage for Screening Programs: Colour Coding High-Risk Patients.","authors":"Carol-Ann Benn, Dominic van Loggereneberg, Charl van Loggereneberg, Bernado Rapoport, Tanya Volschenk","doi":"10.6004/jnccn.2024.7179","DOIUrl":"10.6004/jnccn.2024.7179","url":null,"abstract":"","PeriodicalId":17483,"journal":{"name":"Journal of the National Comprehensive Cancer Network","volume":"23 3.5","pages":""},"PeriodicalIF":14.8,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143743149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信